{
    "relation": [
        [
            "",
            "Stem Cell Arm",
            "Placebo Arm"
        ],
        [
            "Description",
            "Participants will receive active stem cell infusion 2 to 3 weeks after a percutaneous coronary intervention (PCI).",
            "Participants will receive placebo infusion (5% human serum albumin [HSA]) 2 to 3 weeks after a PCI."
        ]
    ],
    "pageTitle": "Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study) - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00684060?sect=X40125&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042987135.9/warc/CC-MAIN-20150728002307-00161-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 862055987,
    "recordOffset": 862039962,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details Enrollment took place at five Network centers and their associated satellite facilities between July 8, 2008 and February 28, 2011. The main centers are located in Ohio, Texas, Florida, Minnesota, and Tennessee. Study brochures, patient informational DVDs, and clinical trials.gov were among the tools used for recruitment. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Biological: Adult stem cells Biological: Placebo Interventions: Left Ventricular Dysfunction Condition: Allocation:\u00a0Randomized; \u00a0 Endpoint\u00a0Classification:\u00a0Safety/Efficacy\u00a0Study; \u00a0 Intervention\u00a0Model:\u00a0Parallel\u00a0Assignment; \u00a0 Masking:\u00a0Double\u00a0Blind\u00a0(Subject,\u00a0Caregiver,\u00a0Investigator,\u00a0Outcomes\u00a0Assessor); \u00a0 Primary\u00a0Purpose:\u00a0Treatment",
    "textAfterTable": "Participant Flow: \u00a0 Overall Study \u00a0 \u00a0 Stem Cell Arm \u00a0 \u00a0 Placebo Arm \u00a0 STARTED \u00a0 \u00a0 58 \u00a0 \u00a0 29 \u00a0 COMPLETED \u00a0 \u00a0 55 \u00a0 \u00a0 26 \u00a0 NOT COMPLETED \u00a0 \u00a0 3 \u00a0 \u00a0 3 \u00a0 Lost to Follow-up \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 New stenosis identified \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 Unable to collect MRI \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}